The Dana-Farber Cancer Institute renewal of support for its Center for AIDS Research (CFAR), which was established in 1989 as part of the Institute's commitment to develop a major research program in AIDS. At that time, the program was focused on the biology of the AIDS virus, anti-viral chemotherapy, and AIDS immunology; NIAID was providing approximately $2.5 million for nine awards in these area. The initial CFAR award provided the means to enhance existing research efforts, promote collaboration and provided the means to enhance existing research efforts, promote collaboration and interaction among Institute investigators, and facilitate the development of innovative AIDS research initiatives by partially supporting existing Biohazard Containment, Molecular Biology, and Pharmacology core facilities, establishing Animal Biohazard Containment and Cell Culture core facilities, and providing a Developmental Program and an administrative function. In the renewal application, continue support is requested for both of the existing containment facilities, the Molecular Biology and Cell Culture Core facilities, and the Developmental and Administration Cores. Additional support is requested for pediatric and adult clinical AIDS cores located at the nearby Children's and Beth Israel Hospitals. The proposed CFAR research program is devoted to gaining an understanding of the molecular aspects of virus-host interactions and encompasses basic laboratory and clinical studies which have an NIAID-Funded Research Base of approximately $6.3 million for some 35 research awards. Specific areas of research included within this thematic approach are centered on therapy, prophylaxis and pathogenesis of AIDS and include pharmacologic, immunologic, and genetic therapy, humoral and cellular immunity and vaccine development, viral cytopathogenesis, opportunistic infection, and AIDS-associated malignancies. The proposed CFAR will provide the infrastructure around which interactive and collaborative research in these areas will be conducted.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI028691-10
Application #
2595855
Study Section
Special Emphasis Panel (SRC (70))
Project Start
1989-09-30
Project End
1999-07-31
Budget Start
1998-08-01
Budget End
1999-07-31
Support Year
10
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Liu, Songtao; Fleysher, Roman; Fleysher, Lazar et al. (2010) Brain metabolites B1-corrected proton T1 mapping in the rhesus macaque at 3 T. Magn Reson Med 63:865-71
Liu, Songtao; Gonen, Oded; Fleysher, Roman et al. (2009) Metabolite proton T(2) mapping in the healthy rhesus macaque brain at 3 T. Magn Reson Med 62:1292-9
Ratai, Eva-Maria; Pilkenton, Sarah J; Greco, Jane B et al. (2009) In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci 10:63
Gonen, Oded; Liu, Songtao; Goelman, Gadi et al. (2008) Proton MR spectroscopic imaging of rhesus macaque brain in vivo at 7T. Magn Reson Med 59:692-9
Ratai, Eva-Maria; Hancu, Ileana; Blezek, Daniel J et al. (2008) Automatic repositioning of MRSI voxels in longitudinal studies: impact on reproducibility of metabolite concentration measurements. J Magn Reson Imaging 27:1188-93
Liu, Songtao; Gonen, Oded; Fleysher, Lazar et al. (2008) Regional metabolite T2 in the healthy rhesus macaque brain at 7T. Magn Reson Med 59:1165-9
Li, Xing; Gold, Bert; O'hUigin, Colm et al. (2007) Unique features of TRIM5alpha among closely related human TRIM family members. Virology 360:419-33
Javanbakht, Hassan; An, Ping; Gold, Bert et al. (2006) Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology 354:15-27
Diaz-Griffero, Felipe; Li, Xing; Javanbakht, Hassan et al. (2006) Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 349:300-15
Gonzalez, R Gilberto; Greco, Jane B; He, Julian et al. (2006) New insights into the neuroimmunity of SIV infection by magnetic resonance spectroscopy. J Neuroimmune Pharmacol 1:152-9

Showing the most recent 10 out of 205 publications